APAC Gamma Butyrolactone Market - Industry Trends and Forecast to 2030
The Asia-Pacific gamma butyrolactone market is projected to register a 3.1% CAGR in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentations
Asia-Pacific Gamma Butyrolactone Market, By Grade (Industrial Class (5 Wt. %), Electric Capacitance Class (9 Wt. %), and Common Class (8 Wt. %)), Purity (Min. 99.9%, and Min. 99.7%), Application (Solvent, Casting Binder, Herbicides and Insecticides, Batteries and Capacitors, Paint Strippers, Polish Removers, Anesthetic, Sedative, and Others), End-Use (Pharmaceutical Industry, Electrical Industry, Agrochemical Industry, Petroleum Industry, Food Industry, and Others ), Country (Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, New Zealand, and the Rest of Asia-Pacific) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Asia-Pacific gamma butyrolactone market:
• Growth of the textile industry
• Increase usage and demand of nail polish removers
Market Players
The key players operating in the Asia-Pacific gamma butyrolactone market are:
• Zhejiang Realsun Chemical Co.,Ltd.
• Biosynth
• BYN Chemical Co., Ltd
• DCC
• BASF SE
• Ashland
• Boai NKY Pharmaceuticals Ltd.
• Mitsubishi Chemical Corporation.
• BALAJI AMINES
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook